Human cytomegalovirus 65 kDa Phosphoprotein Market Report

1.1 Product Definition and Scope

1.2 PEST (Political, Economic, Social and Technological) Analysis of Human cytomegalovirus 65 kDa Phosphoprotein Market

1.3 Market Segment by Type

1.3.1 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of HB-101 from 2016 to 2027

1.3.2 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of CyMVectin from 2016 to 2027

1.3.3 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of ASP-0113 from 2016 to 2027

1.3.4 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of PepVax from 2016 to 2027

1.3.5 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Others from 2016 to 2027

1.4 Market Segment by Application

1.4.1 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Brain Tumor from 2016 to 2027

1.4.2 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Hemotaological Tumor from 2016 to 2027

1.4.3 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Kidney Transplant Rejection from 2016 to 2027

1.4.4 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Liver Transplant Rejection from 2016 to 2027

1.4.5 China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Others from 2016 to 2027

1.5 Market Segment by Regions

2.1 Market Trends and Dynamics

2.2 Competitive Landscape Analysis

2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

3.1 Products Development Trends of Different Types

3.2 Commercial Products Types of Major Vendors

3.3 Competitive Landscape Analysis of Different Types

3.4 Market Size of Human cytomegalovirus 65 kDa Phosphoprotein by Major Types

3.4.1 Market Size and Growth Rate of HB-101

3.4.2 Market Size and Growth Rate of CyMVectin

3.4.3 Market Size and Growth Rate of ASP-0113

3.4.4 Market Size and Growth Rate of PepVax

3.4.5 Market Size and Growth Rate of Others

4.1 Downstream Client Analysis by End-Users

4.2 Competitive Landscape Analysis of Different End-Users

4.3 Market Potential Analysis of Different End-Users

4.4 Market Size of Human cytomegalovirus 65 kDa Phosphoprotein by Major End-Users

4.4.1 Market Size and Growth Rate of Human cytomegalovirus 65 kDa Phosphoprotein in Brain Tumor

4.4.2 Market Size and Growth Rate of Human cytomegalovirus 65 kDa Phosphoprotein in Hemotaological Tumor

4.4.3 Market Size and Growth Rate of Human cytomegalovirus 65 kDa Phosphoprotein in Kidney Transplant Rejection

4.4.4 Market Size and Growth Rate of Human cytomegalovirus 65 kDa Phosphoprotein in Liver Transplant Rejection

4.4.5 Market Size and Growth Rate of Human cytomegalovirus 65 kDa Phosphoprotein in Others

5.1 China Human cytomegalovirus 65 kDa Phosphoprotein Production Analysis by Regions

5.2 China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Analysis by Regions

5.3 Coronavirus (COVID-19) Impact on China Economy

6.1 North China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major Types

6.2 North China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major End-Users

7.1 Central China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major Types

7.2 Central China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major End-Users

8.1 South China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major Types

8.2 South China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major End-Users

9.1 East China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major Types

9.2 East China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major End-Users

10.1 Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major Types

10.2 Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major End-Users

11.1 Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major Types

11.2 Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major End-Users

12.1 Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major Types

12.2 Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Landscape Analysis by Major End-Users

13.1 Vaximm AG

13.2 VBI Vaccines Inc

13.3 Vakzine Projekt Management GmbH

13.4 Hookipa Biotech AG

13.5 Immunomic Therapeutics Inc

13.6 Astellas Pharma Inc

13.7 Vical Inc

Figure Product Picture

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of HB-101 from 2016 to 2027

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of CyMVectin from 2016 to 2027

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of ASP-0113 from 2016 to 2027

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of PepVax from 2016 to 2027

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Others from 2016 to 2027

Figure Market Share by Type in 2016

Figure Market Share by Type in 2021

Figure Market Share by Type in 2027

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Brain Tumor from 2016 to 2027

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Hemotaological Tumor from 2016 to 2027

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Kidney Transplant Rejection from 2016 to 2027

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Liver Transplant Rejection from 2016 to 2027

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Market Size and Growth Rate of Others from 2016 to 2027

Figure Market Share by End-User in 2016

Figure Market Share by End-User in 2021

Figure Market Share by End-User in 2027

Figure North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Size and Growth Rate from 2016 to 2027

Figure Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Size and Growth Rate from 2016 to 2027

Figure South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Size and Growth Rate from 2016 to 2027

Figure East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Size and Growth Rate from 2016 to 2027

Figure Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Market Size and Growth Rate from 2016 to 2027

Figure Development Trends and Industry Dynamics of Human cytomegalovirus 65 kDa Phosphoprotein Industry

Figure Market Challenges and Restraints

Figure Market Opportunities and Potentials

Table Mergers and Acquisition

Figure Market Share of TOP 3 Players in 2020

Figure Market Share of TOP 5 Players in 2021

Figure Market Share of TOP 6 Players from 2016 to 2021

Figure Porter's Five Forces Analysis

Figure New Entrant SWOT Analysis

Figure Coronavirus (COVID-19) Map of China

Table Coronavirus (COVID-19) Impact on the Industry

Figure Specifications of Different Types of Human cytomegalovirus 65 kDa Phosphoprotein

Figure Development Trends of Different Types

Table Commercial Products Types of Major Vendors

Figure Competitive Landscape Analysis of Different Types

Table Consumption of Human cytomegalovirus 65 kDa Phosphoprotein by Different Types from 2016 to 2027

Table Consumption Share of Human cytomegalovirus 65 kDa Phosphoprotein by Different Types from 2016 to 2027

Figure Market Size and Growth Rate of HB-101

Figure Market Size and Growth Rate of CyMVectin

Figure Market Size and Growth Rate of ASP-0113

Figure Market Size and Growth Rate of PepVax

Figure Market Size and Growth Rate of Others

Table Downstream Client Analysis by End-Users

Figure Competitive Landscape Analysis of Different End-Users

Table Market Potential Analysis of Different End-Users

Figure Consumption of Human cytomegalovirus 65 kDa Phosphoprotein by Different End-Users from 2016 to 2027

Table Consumption Share of Human cytomegalovirus 65 kDa Phosphoprotein by Different End-Users from 2016 to 2027

Figure Market Size and Growth Rate of Brain Tumor

Figure Market Size and Growth Rate of Hemotaological Tumor

Figure Market Size and Growth Rate of Kidney Transplant Rejection

Figure Market Size and Growth Rate of Liver Transplant Rejection

Figure Market Size and Growth Rate of Others

Table China Human cytomegalovirus 65 kDa Phosphoprotein Production by Regions

Table China Human cytomegalovirus 65 kDa Phosphoprotein Production Share by Regions

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Share by Regions in 2016

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Share by Regions in 2021

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Production Share by Regions in 2027

Table China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Regions

Table China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Regions

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Regions in 2016

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Regions in 2021

Figure China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Regions in 2027

Table North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Types from 2016 to 2027

Table North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types from 2016 to 2027

Figure North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2016

Figure North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2021

Figure North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2027

Table North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by End-Users from 2016 to 2027

Table North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users from 2016 to 2027

Figure North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2016

Figure North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2021

Figure North China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2027

Table Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Types from 2016 to 2027

Table Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types from 2016 to 2027

Figure Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2016

Figure Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2021

Figure Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2027

Table Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by End-Users from 2016 to 2027

Table Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users from 2016 to 2027

Figure Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2016

Figure Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2021

Figure Central China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2027

Table South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Types from 2016 to 2027

Table South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types from 2016 to 2027

Figure South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2016

Figure South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2021

Figure South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2027

Table South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by End-Users from 2016 to 2027

Table South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users from 2016 to 2027

Figure South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2016

Figure South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2021

Figure South China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2027

Table East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Types from 2016 to 2027

Table East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types from 2016 to 2027

Figure East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2016

Figure East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2021

Figure East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2027

Table East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by End-Users from 2016 to 2027

Table East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users from 2016 to 2027

Figure East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2016

Figure East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2021

Figure East China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2027

Table Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Types from 2016 to 2027

Table Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types from 2016 to 2027

Figure Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2016

Figure Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2021

Figure Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2027

Table Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by End-Users from 2016 to 2027

Table Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users from 2016 to 2027

Figure Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2016

Figure Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2021

Figure Northeast China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2027

Table Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Types from 2016 to 2027

Table Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types from 2016 to 2027

Figure Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2016

Figure Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2021

Figure Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2027

Table Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by End-Users from 2016 to 2027

Table Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users from 2016 to 2027

Figure Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2016

Figure Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2021

Figure Southwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2027

Table Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by Types from 2016 to 2027

Table Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types from 2016 to 2027

Figure Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2016

Figure Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2021

Figure Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by Types in 2027

Table Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption by End-Users from 2016 to 2027

Table Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users from 2016 to 2027

Figure Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2016

Figure Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2021

Figure Northwest China Human cytomegalovirus 65 kDa Phosphoprotein Consumption Share by End-Users in 2027

Table Company Profile and Development Status of Vaximm AG

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaximm AG

Figure Sales and Growth Rate Analysis of Vaximm AG

Figure Revenue and Market Share Analysis of Vaximm AG

Table Product and Service Introduction of Vaximm AG

Table Company Profile and Development Status of VBI Vaccines Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of VBI Vaccines Inc

Figure Sales and Growth Rate Analysis of VBI Vaccines Inc

Figure Revenue and Market Share Analysis of VBI Vaccines Inc

Table Product and Service Introduction of VBI Vaccines Inc

Table Company Profile and Development Status of Vakzine Projekt Management GmbH

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vakzine Projekt Management GmbH

Figure Sales and Growth Rate Analysis of Vakzine Projekt Management GmbH

Figure Revenue and Market Share Analysis of Vakzine Projekt Management GmbH

Table Product and Service Introduction of Vakzine Projekt Management GmbH

Table Company Profile and Development Status of Hookipa Biotech AG

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hookipa Biotech AG

Figure Sales and Growth Rate Analysis of Hookipa Biotech AG

Figure Revenue and Market Share Analysis of Hookipa Biotech AG

Table Product and Service Introduction of Hookipa Biotech AG

Table Company Profile and Development Status of Immunomic Therapeutics Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomic Therapeutics Inc

Figure Sales and Growth Rate Analysis of Immunomic Therapeutics Inc

Figure Revenue and Market Share Analysis of Immunomic Therapeutics Inc

Table Product and Service Introduction of Immunomic Therapeutics Inc

Table Company Profile and Development Status of Astellas Pharma Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc

Figure Sales and Growth Rate Analysis of Astellas Pharma Inc

Figure Revenue and Market Share Analysis of Astellas Pharma Inc

Table Product and Service Introduction of Astellas Pharma Inc

Table Company Profile and Development Status of Vical Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vical Inc

Figure Sales and Growth Rate Analysis of Vical Inc

Figure Revenue and Market Share Analysis of Vical Inc

Table Product and Service Introduction of Vical Inc